About this trial
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures to determine whether these can predict autism diagnoses in both children exposed to HIV and uninfected (CHEU) and children not exposed to HIV and uninfected (CHUU).
Eligibility criteria
Qualifiers
Children enrolled in the Tabiri study (R01HD104552)
CHEU or CHUU
Children ages 24-72 months
Caregivers of children must speak Kiswahili (local language) or English.
Disqualifiers
There will be no specific exclusion criteria. We anticipate that a small number of CHEU and CHUU will develop HIV prior to enrollment in the current study; these children will be included and will follow all general study procedures.
Trial design
Treatments tested in this trial
- Eyelink Portable Duo
Treatment groups
Sponsors and collaborators
Indiana University
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator